Digital Sponsored Harnessing omnichannel, AI, and beyond: Reimagining scientif... Artificial intelligence (AI) and omnichannel have come to seem mere buzzwords these days in the life sciences – everyone is talking about them, everyone wants to use them.
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
